Azoximer bromide

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Azoximer bromide
Azoximer bromide.svg
Clinical data
SynonymsPolyoxidonium, Synpol
ATC code
Pharmacokinetic data
Bioavailabilityup to 89%
Elimination half-life25.4 hours (intravenous routes)
CAS Number
  • none
Chemical and physical data
Molar mass60000–100000 g/mol

Polyoxidonium is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.

Polyoxidonium is registered in US Patent-5503830 from 1996,[1][2][3] in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.[4]

References[change | change source]

  4. State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003